Stock Ratings / Consumer Discretionary / BNKK / earnings

BYAH (57) CABR (38) YCBD (43) UG (70) ⌘ Pro Terminal →

Bonk Inc. (BNKK) Next Earnings Date & Expected ±12.5% Move

$1.18 -2.48% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Bonk Inc. (BNKK) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $9.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-5.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BNKK)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.15 Expected Swing

MODEL EARNINGS SETUP GAUGE

BNKK Quantitative Pre-Earnings Setup: 45/100

Trailing EPS: $4.25 • YoY Revenue Growth: 180%

Model Bullish Setup (45/100)Model Risk Weight (55/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$2.1M	-$68.2M	-$25.3M	58.5%
FY 2024	2024-12-31	$702.0K	-$49.4M	-$18.2M	-50%
FY 2023	2023-12-31	$202.7K	-$15.1M	-$10.5M	58.5%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BNKK)

✓Walkthrough of BNKK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BNKK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -54.09%📐 HORIZONTAL RANGE

2026-10-30O $1.14H $1.18L $1.06C $1.18VOL 72.4K

RES: $2.41SUP: $0.90SMA50: $1.36SMA200: $2.14

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BNKK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BNKK Butterfly Map → + Track BNKK →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BNKK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BNKK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BNKK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BNKK)

Consumer Discretionary Rank #758 of 1011 ⚔️ BYAH vs BNKK Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BNKK vs. BYAH, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Bonk Inc. (BNKK) ranks #758 by composite RQD confidence (45/100, grade D) and #931 by equity capitalization ($9.4M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with BNKK at 45/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BNKK ACTIVE Bonk Inc.	D	45/100	—	58.5%	-35.0%	-2.48%	$9.4M	Benchmark Subject
BYAH Park Ha Biological Technology Co. Ltd. (Class A)	D+	57/100	—	94.4%	—	+1.71%	$7.9M	/byah-vs-bnkk →
CABR Caring Brands Inc.	D-	38/100	—	55.6%	-35.0%	-4.46%	$11.2M	/cabr-vs-bnkk →
YCBD cbdMD Inc.	D-	43/100	—	62.4%	-30.4%	+4.56%	$4.3M	/ycbd-vs-bnkk →
UG United-Guardian Inc.	B-	70/100	14.5x	—	17.8%	-1.19%	$30.6M	/ug-vs-bnkk →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001760903

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bonk Inc. (BNKK) reported GAAP revenue of $2.1M (+201.6% vs. FY2024 revenue of $702.0K , and +944.7% cumulative change since FY2023) , GAAP net income of -$68.2M, operating cash flow of -$25.3M, and free cash flow of -$25.3M (-39.1% YoY). On the balance sheet, BNKK closed FY2025 with $41.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$2.1M	-$68.2M	-$25.3M	-$25.3M	$41.0M	—
FY2024 (FY)	2024-12-31	$702.0K	-$49.4M	-$18.1M	-$18.2M	$7.3M	—
FY2023 (FY)	2023-12-31	$202.7K	-$15.1M	-$10.5M	-$10.5M	—	—

3. BNKK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Bonk Inc. (NASDAQ: BNKK) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $1.18 (-2.48% 1D, market cap $9.4M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, BNKK ranks #758 in composite RQD confidence.

How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D+ grade (57/100 RQD, P/E N/A, ROIC —, cap $7.9M) and CABR (Caring Brands Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BNKK?

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BNKK trading relative to its 50-day, 200-day, and 52-week technical levels?

BNKK last traded at $1.18 (-2.48% on volume of 34,872 shares), positioning the stock -13.24% below its 50-day simple moving average ($1.36) and -44.86% below its 200-day simple moving average ($2.14). Across its 52-week range of $0.90 to $8.89, BNKK sits at the 3.5% percentile with a 14-day RSI of 38.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.03 to $1.33).